Bowen Yao

3.2k total citations
51 papers, 1.9k citations indexed

About

Bowen Yao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bowen Yao has authored 51 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 34 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Bowen Yao's work include Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (18 papers) and RNA modifications and cancer (14 papers). Bowen Yao is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (18 papers) and RNA modifications and cancer (14 papers). Bowen Yao collaborates with scholars based in China, United States and Saudi Arabia. Bowen Yao's co-authors include Zhikui Liu, Kangsheng Tu, Qingguang Liu, Yufeng Wang, Liang Wang, Liankang Sun, Tianxiang Chen, Wei Yang, Meng Xu and Qing Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Bowen Yao

49 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bowen Yao China 27 1.4k 1.2k 284 157 156 51 1.9k
Xian Lin China 23 1.2k 0.9× 637 0.5× 476 1.7× 181 1.2× 99 0.6× 63 1.7k
Daimin Xiang China 17 1.2k 0.8× 764 0.6× 301 1.1× 92 0.6× 200 1.3× 28 1.6k
Changwei Dou China 22 1.2k 0.8× 852 0.7× 334 1.2× 245 1.6× 198 1.3× 46 1.8k
Qingguang Liu China 21 855 0.6× 531 0.4× 213 0.8× 125 0.8× 110 0.7× 55 1.2k
Lynn Kirkpatrick United States 15 991 0.7× 679 0.6× 295 1.0× 179 1.1× 74 0.5× 23 1.6k
Juanjuan Shan China 24 1.4k 1.0× 735 0.6× 635 2.2× 130 0.8× 172 1.1× 41 2.1k
Longjuan Zhang China 27 1.4k 1.0× 860 0.7× 462 1.6× 149 0.9× 112 0.7× 55 2.0k
Peifen Fu China 24 1.1k 0.8× 856 0.7× 428 1.5× 158 1.0× 76 0.5× 54 1.6k
Qingguang Liu China 32 1.9k 1.3× 1.4k 1.2× 466 1.6× 196 1.2× 243 1.6× 67 2.7k
Matjaž Rokavec Germany 18 1.2k 0.9× 1.1k 0.9× 591 2.1× 162 1.0× 91 0.6× 30 1.9k

Countries citing papers authored by Bowen Yao

Since Specialization
Citations

This map shows the geographic impact of Bowen Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowen Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowen Yao more than expected).

Fields of papers citing papers by Bowen Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bowen Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowen Yao. The network helps show where Bowen Yao may publish in the future.

Co-authorship network of co-authors of Bowen Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Bowen Yao. A scholar is included among the top collaborators of Bowen Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bowen Yao. Bowen Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yazhao, Haoyu Wang, Jingyu Li, et al.. (2024). Interleukin-41: a novel serum marker for the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma. Frontiers in Oncology. 14. 1408584–1408584. 3 indexed citations
2.
Yao, Bowen, et al.. (2023). SmRAV1, an AP2 and B3 Transcription Factor, Positively Regulates Eggplant’s Response to Salt Stress. Plants. 12(24). 4174–4174. 3 indexed citations
3.
Yao, Bowen, et al.. (2023). BCLAF1-induced HIF-1α accumulation under normoxia enhances PD-L1 treatment resistances via BCLAF1-CUL3 complex. Cancer Immunology Immunotherapy. 72(12). 4279–4292. 4 indexed citations
4.
Yang, Si, Bowen Yao, Liming Wu, et al.. (2021). Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma. Molecular Therapy — Oncolytics. 21. 207–219. 6 indexed citations
5.
Feng, Ming, Huanhuan Wang, Zhiyuan Zhu, et al.. (2021). Sanhuang Decoction Controls Tumor Microenvironment by Ameliorating Chronic Stress in Breast Cancer: A Report of Ninety Cases. Frontiers in Oncology. 11. 677939–677939. 5 indexed citations
6.
Yang, Nan, Tianxiang Chen, Liang Wang, et al.. (2020). CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway. Theranostics. 10(13). 5790–5801. 72 indexed citations
7.
Yao, Bowen, et al.. (2020). BICD1 functions as a prognostic biomarker and promotes hepatocellular carcinoma progression. Pathology - Research and Practice. 216(4). 152858–152858. 5 indexed citations
8.
Yang, Xue, Liankang Sun, Liang Wang, et al.. (2019). LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Biomedicine & Pharmacotherapy. 118. 109386–109386. 58 indexed citations
9.
Han, Shaoshan, Liang Wang, Liankang Sun, et al.. (2019). MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12. Biomedicine & Pharmacotherapy. 122. 109754–109754. 31 indexed citations
10.
Wang, Liang, Huanye Mo, Yufeng Wang, et al.. (2019). MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3. Biomedicine & Pharmacotherapy. 118. 109267–109267. 21 indexed citations
11.
Wang, Liang, Bowen Yao, Wei Yang, et al.. (2019). MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP. Biomedicine & Pharmacotherapy. 118. 109343–109343. 22 indexed citations
12.
Wang, Liang, et al.. (2019). miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Biomedicine & Pharmacotherapy. 117. 109055–109055. 38 indexed citations
13.
Sun, Liankang, Yufeng Wang, Liang Wang, et al.. (2019). Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. Journal of Experimental & Clinical Cancer Research. 38(1). 170–170. 103 indexed citations
14.
Wang, Yufeng, Liang Wang, Liankang Sun, et al.. (2018). miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT. Biomedicine & Pharmacotherapy. 109. 991–999. 44 indexed citations
15.
Wang, Yufeng, Liankang Sun, Liang Wang, et al.. (2018). Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma. Cell Death and Disease. 9(9). 851–851. 108 indexed citations
16.
Tao, Jie, Zhikui Liu, Yufeng Wang, et al.. (2017). MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. Biomedicine & Pharmacotherapy. 93. 420–428. 38 indexed citations
17.
Jia, Yuli, Meng Xu, Changwei Dou, et al.. (2016). P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy. Cell Death and Disease. 7(10). e2400–e2400. 37 indexed citations
18.
Tu, Kangsheng, Zhikui Liu, Bowen Yao, et al.. (2016). BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1. Oncology Reports. 35(4). 2382–2390. 21 indexed citations
19.
Tu, Kangsheng, Zhikui Liu, Bowen Yao, Shaoshan Han, & Wei Yang. (2015). MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma. International Journal of Oncology. 48(3). 965–974. 100 indexed citations
20.
Shao, Yuan, Yiping Qu, Siwen Dang, Bowen Yao, & Meiju Ji. (2013). MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6. Cancer Cell International. 13(1). 51–51. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xian Lin Breakdown of academic impact, for papers by Daimin Xiang Breakdown of academic impact, for papers by Changwei Dou Breakdown of academic impact, for papers by Qingguang Liu Breakdown of academic impact, for papers by Lynn Kirkpatrick Breakdown of academic impact, for papers by Juanjuan Shan Breakdown of academic impact, for papers by Longjuan Zhang Breakdown of academic impact, for papers by Peifen Fu Breakdown of academic impact, for papers by Qingguang Liu Breakdown of academic impact, for papers by Matjaž Rokavec
Rankless by CCL
2026